Showing 361 - 380 results of 99,520 for search '(( 5 non decrease ) OR ( 5 ((step decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.45s Refine Results
  1. 361
  2. 362
  3. 363
  4. 364

    Influenza virus infection decreases CLEC7A (Dectin1) mRNA and reduces phagocytosis of zymosan by AM. by Jieru Wang (179734)

    Published 2012
    “…<p>Panel A. Human AM were cultured and infected by PR/8 at a MOI of 0.5. …”
  5. 365

    The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

    Published 2019
    “…<p>(A) Effect of Hsp90α ASO on cell viability. Differentiated SH-SY5Y cells were transfected with different concentrations of Hsp90α ASO. …”
  6. 366
  7. 367
  8. 368

    Average radiant efficiency (± SEM) in equally sized regions of interest (ROIs) of the non-pregnant uterus. by Kalman F. Szucs (19353218)

    Published 2024
    “…<p>A significant decrease in αvβ3 integrin was observed in the PET imaging procedure. (***: p < 0.001).…”
  9. 369
  10. 370
  11. 371
  12. 372
  13. 373

    The MMP was decreased by incubation with CytoD or LatB. by Dong-Hee Yang (566631)

    Published 2014
    “…An MMP collapse was detected as a decrease in the percentage of cells with high red fluorescence intensity. …”
  14. 374
  15. 375

    Depletion of SNEV decreases the splicing efficiency of nuclear extracts by Johannes Grillari (13055)

    Published 2011
    “…Lane 1 shows the unspliced adenoviral pre-mRNA. A decrease of the second catalytical step of the reaction was observed in the SNEV depleted extracts when compared to depleted controls, where irrelevant antibodies were used for depletion (lanes 3 and 4) or where untreated NE was used for splicing (lane 2). …”
  16. 376
  17. 377
  18. 378

    Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

    Published 2015
    “…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”
  19. 379
  20. 380